🇮🇹 Kyprolis in Italy

Kyprolis (carfilzomib) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Kyprolis
  • Status: approved

Kyprolis in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Italy

Frequently asked questions

Is Kyprolis approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for Kyprolis in Italy?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.